Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease

scientific article published on September 30, 1995

Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0360-3016(95)00180-7
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0360301695001807?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:0360301695001807?httpAccept=text/xml
P698PubMed publication ID7673013

P2093author name stringS. Williams
R. R. Weichselbaum
D. Hallahan
G. Sibley
A. J. Mundt
J. Nautiyal
P2860cites workCombined modality therapy for advanced Hodgkin's disease: 15-year follow-up dataQ30755039
Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study GroupQ33492326
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary dataQ33569688
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseQ34938238
High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's diseaseQ36027181
High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's diseaseQ36467526
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potentialQ38179832
The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease.Q40711339
Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapyQ43639919
High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's diseaseQ44413336
Autologous bone marrow transplantation for patients with relapsed hodgkin's diseaseQ45059370
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.Q54238415
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease.Q54242190
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.Q54378283
Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.Q54401246
Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donorsQ68013001
Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinationsQ68072150
Improved survival in advanced Hodgkin's disease with the use of combined modality therapyQ68555301
Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's diseaseQ68965879
Allogeneic marrow transplantation for refractory Hodgkin's diseaseQ69088187
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's diseaseQ69484546
Interstitial pneumonitis following autologous bone marrow transplantationQ70155781
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year updateQ71612270
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapyQ72181293
Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized studyQ72396026
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experienceQ72621743
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
P304page(s)261-270
P577publication date1995-09-01
1995-09-30
P1433published inInternational Journal of Radiation Oncology Biology PhysicsQ2296252
P1476titlePatterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease
P478volume33